Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioma × poly ICLC × Clear all

Phase

Status

Completed 3 Terminated 2 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Neoplasms 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Melanoma 1 Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 15 Temozolomide 11 Specimen Handling 10 X-Rays 8 Radiotherapy 7 Biopsy 7 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 trametinib 5 dabrafenib 4 ulixertinib 3 olaparib 3 larotrectinib 3 erdafitinib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Nivolumab 3 tipifarnib 2 selpercatinib 2 pembrolizumab 2 palbociclib 2 niraparib 2 ivosidenib 2 ensartinib 2 atezolizumab 2 abemaciclib 2 Surveys and Questionnaires 2 Proton Therapy 2 Lomustine 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05283109 2025-10-31

ETAPA I

Duke University

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡